The purpose of this study is to compare effects of the study drug fosmanogepix with already-approved drugs caspofungin and fluconazole to find out if fosmanogepix is safe and effective in treating patients with candidemia and/or invasive candidiasis.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Anne Lachiewicz
Medicine-ID Transplant Compromised Host
Clinical or Medical
Interventional
Blood Conditions
24-1761
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
